QuickView for bruceantin (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. Prostate carcinoma 22RV1 cells treated with the potent HSP90 inhibitor bruceantin
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

1. Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate …
2. Anionic polycyclization entry to tricycles related to quassinoids and terpenoids: a stereocontrolled…
3. Bruceantin inhibits multiple myeloma cancer stem cell proliferation.
4. U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin…
5. NF-kappaB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen specie…

There were no clinical trials for bruceantin